Tag: ascendis pharma

July 19, 2019

Ascendis Pharma Files Investigational New Drug Application for Phase 2 Trial of TransCon

Ascendis Pharma (NASDAQ:ASND) has announced it has filed an investigational new drug application with the US Food and Drug Administration...
November 29, 2018

Ascendis Pharma Reports Third Quarter 2018 Financial Results

Ascendis Pharma (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today announced financial...
November 29, 2018

Ascendis Pharma Announces Positive Preliminary Phase 1 Data for TransCon CNP

Ascendis Pharma (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today announced positive...
June 7, 2018

Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism

Ascendis Pharma (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today announced...